Key for crossing the BBB with nanoparticles: the rational design

Scholarly Works

• Liu, S.; Li, H.; Xi, S.; Zhang, Y.; Sun, T. Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies. International journal of nanomedicine 2025, 20, 1443–1490. doi:10.2147/ijn.s457393
• Okafor, N. I.; Omoteso, O. A.; Choonara, Y. E. The modification of conventional liposomes for targeted antimicrobial delivery to treat infectious diseases. Discover nano 2025, 20, 19. doi:10.1186/s11671-024-04170-x
• Ismail, M.; Liu, J.; Wang, N.; Zhang, D.; Qin, C.; Shi, B.; Zheng, M. Advanced nanoparticle engineering for precision therapeutics of brain diseases. Biomaterials 2025, 318, 123138. doi:10.1016/j.biomaterials.2025.123138
• Ortiz-Islas, E.; Montes, P.; Rodríguez-Pérez, C. E.; Ruiz-Sánchez, E.; Sánchez-Barbosa, T.; Pichardo-Rojas, D.; Zavala-Tecuapetla, C.; Carvajal-Aguilera, K.; Campos-Peña, V. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128. doi:10.3390/pharmaceutics17010128
• Yanamadala, Y.; Muthumula, C. M. R.; Khare, S.; Gokulan, K. Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration. International journal of nanomedicine 2025, 20, 367–402. doi:10.2147/ijn.s494224
• Luo, Q.; Yang, J.; Yang, M.; Wang, Y.; Liu, Y.; Liu, J.; Kalvakolanu, D. V.; Cong, X.; Zhang, J.; Zhang, L.; Guo, B.; Duo, Y. Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system. Materials today. Bio 2025, 31, 101457. doi:10.1016/j.mtbio.2025.101457
• Kumari, M.; Kumar, A.; Baldi, A. Drug delivery to brain: Formulation challenges and potential approaches. Novel Drug Delivery Systems in the management of CNS Disorders; Elsevier, 2025; pp 15–38. doi:10.1016/b978-0-443-13474-6.00027-5
• Pratap, G. K.; Poornima, D. V.; Vadlapudi, K.; Ruksana, F. Nanomedicine-Based Drug Delivery Systems for Treating Neurodegenerative Diseases. Encyclopedia of Green Materials; Springer Nature Singapore, 2024; pp 1454–1462. doi:10.1007/978-981-97-4618-7_149
• Soleymani, S.; Doroudian, M.; Soezi, M.; Beladi, A.; Asgari, K.; Mobarakshahi, A.; Aghaeipour, A.; Macloughlin, R. Engendered nanoparticles for treatment of brain tumors. Oncology research 2024, 33, 15–26. doi:10.32604/or.2024.053069
• Tiwari, S.; Chaturvedi, S.; Kaul, A.; Choudhary, V.; Barthélémy, P.; Mishra, A. K. Development of amphiphilic self-assembled nucleolipid as BBB targeting probe based on SPECT. Discover nano 2024, 19, 210. doi:10.1186/s11671-024-04129-y
• Luo, W.; Chen, C.; Guo, X.; Guo, X.; Zheng, J.; Liu, J.; Fan, X.; Luo, M.; Yu, Z.; Li, H.; Liu, J.; Wang, Y. Critical Challenges of Intravenous Nanomaterials Crossing the Blood‐Brain Barrier: from Blood to Brain. Advanced Functional Materials 2024, 35. doi:10.1002/adfm.202409522
• Yang, H.; Tan, H.; Wen, H.; Xin, P.; Liu, Y.; Deng, Z.; Xu, Y.; Gao, F.; Zhang, L.; Ye, Z.; Zhang, Z.; Chen, Y.; Wang, Y.; Sun, J.; Lam, J. W. Y.; Zhao, Z.; Kwok, R. T. K.; Qiu, Z.; Tang, B. Z. Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer's Diseases. ACS nano 2024, 18, 33792–33826. doi:10.1021/acsnano.4c11966
• Chakraborty, B.; Patel, G.; Padhan, B.; Das, J.; Patel, M. Evolution of lipid nanoparticles as charioteers of Alzheimer's disease therapeutics. Applied Materials Today 2024, 41, 102442. doi:10.1016/j.apmt.2024.102442
• Hanumanthappa, R.; Parthasarathy, A.; Heggannavar, G. B.; PC, K.; Nanjaiah, H.; Kumbhar, R.; Devaraju, K. S. Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co‐modified polymer nanoparticles. Neuroprotection 2024, 2, 255–275. doi:10.1002/nep3.60
• Yao, Y.; Bei, F. Adeno-associated Virus-Mediated Gene Delivery Across the Blood-Brain Barrier. Advances in neurobiology 2024, 41, 91–112. doi:10.1007/978-3-031-69188-1_4
• de Moraes, B. P. T.; da Silva, K. P.; Paese, K.; Sinhorin, A. P.; Guterres, S. S.; Pohlmann, A. R.; Moraes-de-Souza, I.; de Oliveira Rodrigues, S.; SouzaSouza, K. F. C. E.; da Cunha, C. M. C.; de Almeida, M. A. P.; Bozza, P. T.; de Castro-Faria-Neto, H. C.; Silva, A. R.; Gonçalves-de-Albuquerque, C. F.; Ferrarini, S. R. Effects of nanocapsules containing lumefantrine and artemether in an experimental model of cerebral malaria. Discover nano 2024, 19, 184. doi:10.1186/s11671-024-04121-6
• Chen, J.; Yang, W.-Z.; Chen, H.; Ding, X.; Chen, H.; Zhan, C.-H.; Jin, Z. Targeting protein aggregation: the promising application of polyoxometalates in neurodegenerative diseases. Inorganic Chemistry Frontiers 2024, 11, 7238–7255. doi:10.1039/d4qi01945h
• Rafati, N.; Zarepour, A.; Bigham, A.; Khosravi, A.; Naderi-Manesh, H.; Iravani, S.; Zarrabi, A. Nanosystems for targeted drug Delivery: Innovations and challenges in overcoming the Blood-Brain barrier for neurodegenerative disease and cancer therapy. International journal of pharmaceutics 2024, 666, 124800. doi:10.1016/j.ijpharm.2024.124800
• Ijaz, M.; Hasan, I.; Jiang, Z.; Ullah, Z.; Aslam, B.; Khurshid, M.; Sun, Y.; Guo, B. Combinatory Immunotherapy for Glioblastoma Treatment. Advanced Therapeutics 2024, 7. doi:10.1002/adtp.202400217
• Devi, C. M.; Deka, K.; Das, A. K.; Talukdar, A.; Sola, P. Recent Advances in Marine-Derived Nanoformulation for the Management of Glioblastoma. Molecular biotechnology 2024. doi:10.1007/s12033-024-01287-3

Explore citations to this article at